Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
[FOSMED--a file-oriented system for medical diagnosis].

Verhandlungen der Deutschen Gesellschaft fur Innere Medizin

Blomer RJ, Schikora R, Schimetzek H.
PMID: 4616517
Verh Dtsch Ges Inn Med. 1974;80:933-4.

No abstract available.

Cite
Blomer RJ, Schikora R, Schimetzek H. FOSMED - ein File-orientiertes System für medizinische Diagnostik [FOSMED--a file-oriented system for medical diagnosis]. Verh Dtsch Ges Inn Med. 1974;80:933-4
Blomer, R. J., Schikora, R., & Schimetzek, H. (1974). FOSMED - ein File-orientiertes System für medizinische Diagnostik [FOSMED--a file-oriented system for medical diagnosis]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 80933-4.
Blomer, R J, et al. "FOSMED - ein File-orientiertes System für medizinische Diagnostik" [FOSMED--a file-oriented system for medical diagnosis]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin vol. 80 (1974): 933-4.
Blomer RJ, Schikora R, Schimetzek H. FOSMED - ein File-orientiertes System für medizinische Diagnostik [FOSMED--a file-oriented system for medical diagnosis]. Verh Dtsch Ges Inn Med. 1974;80:933-4. German. PMID: 4616517.
Copy Download .nbib Format: NLM
Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.

Frontiers in immunology

Dickinson AM, Norden J, Li S, Hromadnikova I, Schmid C, Schmetzer H, Jochem-Kolb H.
PMID: 28638379
Front Immunol. 2017 Jun 07;8:496. doi: 10.3389/fimmu.2017.00496. eCollection 2017.

The success of hematopoietic stem cell transplantation (HSCT) lies with the ability of the engrafting immune system to remove residual leukemia cells

Cite
Dickinson AM, Norden J, Li S, et al. Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia. Front Immunol. 2017;8:496doi: 10.3389/fimmu.2017.00496.
Dickinson, A. M., Norden, J., Li, S., Hromadnikova, I., Schmid, C., Schmetzer, H., & Jochem-Kolb, H. (2017). Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia. Frontiers in immunology, 8496. https://doi.org/10.3389/fimmu.2017.00496
Dickinson, Anne M, et al. "Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia." Frontiers in immunology vol. 8 (2017): 496. doi: https://doi.org/10.3389/fimmu.2017.00496
Dickinson AM, Norden J, Li S, Hromadnikova I, Schmid C, Schmetzer H, Jochem-Kolb H. Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia. Front Immunol. 2017 Jun 07;8:496. doi: 10.3389/fimmu.2017.00496. eCollection 2017. PMID: 28638379; PMCID: PMC5461268.
Copy Download .nbib Format: NLM
Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse.

Immunobiology

Schmohl J, Guenther T, Sutanto W, Schuster F, Kroell T, Hartmann A, Salih H, Stoetzer O, Schmetzer H.
PMID: 33485134
Immunobiology. 2021 Jan;226(1):152048. doi: 10.1016/j.imbio.2020.152048. Epub 2020 Dec 16.

BACKGROUND: The High Mobility Group Box 1 (HMGB1) is a nuclear protein that is frequently overexpressed in hematologic diseases and might be of relevance in immunogenic cancer control thus correlating with patients' (pts.) prognosis in diseases such as acute...

Cite
Schmohl J, Guenther T, Sutanto W, et al. Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse. Immunobiology. 2020;226(1):152048doi: 10.1016/j.imbio.2020.152048.
Schmohl, J., Guenther, T., Sutanto, W., Schuster, F., Kroell, T., Hartmann, A., Salih, H., Stoetzer, O., & Schmetzer, H. (2021). Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse. Immunobiology, 226(1), 152048. https://doi.org/10.1016/j.imbio.2020.152048
Schmohl, Joerg, et al. "Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse." Immunobiology vol. 226,1 (2021): 152048. doi: https://doi.org/10.1016/j.imbio.2020.152048
Schmohl J, Guenther T, Sutanto W, Schuster F, Kroell T, Hartmann A, Salih H, Stoetzer O, Schmetzer H. Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse. Immunobiology. 2021 Jan;226(1):152048. doi: 10.1016/j.imbio.2020.152048. Epub 2020 Dec 16. PMID: 33485134.
Copy Download .nbib Format: NLM
Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes.

BMC ophthalmology

Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT.
PMID: 27473341
BMC Ophthalmol. 2016 Jul 29;16(1):129. doi: 10.1186/s12886-016-0259-4.

No abstract available.

Cite
Ghodasra DH, Chen A, Arevalo JF, et al. Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC Ophthalmol. 2016;16(1):129doi: 10.1186/s12886-016-0259-4.
Ghodasra, D. H., Chen, A., Arevalo, J. F., Birch, D. G., Branham, K., Coley, B., Dagnelie, G., de Juan, E., Devenyi, R. G., Dorn, J. D., Fisher, A., Geruschat, D. R., Gregori, N. Z., Greenberg, R. J., Hahn, P., Ho, A. C., Howson, A., Huang, S. S., Iezzi, R., Khan, N., Lam, B. L., Lim, J. I., Locke, K. G., Markowitz, M., Ripley, A. M., Rankin, M., Schimitzek, H., Tripp, F., Weiland, J. D., Yan, J., Zacks, D. N., & Jayasundera, K. T. (2016). Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC ophthalmology, 16(1), 129. https://doi.org/10.1186/s12886-016-0259-4
Ghodasra, Devon H, et al. "Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes." BMC ophthalmology vol. 16,1 (2016): 129. doi: https://doi.org/10.1186/s12886-016-0259-4
Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT. Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC Ophthalmol. 2016 Jul 29;16(1):129. doi: 10.1186/s12886-016-0259-4. PMID: 27473341; PMCID: PMC4965894.
Copy Download .nbib Format: NLM
α-Iodoalkyl-Iodine-Ate Complexes as Observable Intermediates in the Iodine- Magnesium Exchange Reaction.

Angewandte Chemie (International ed. in English)

Schulze V, Brönstrup M, Böhm VPW, Schwerdtfeger P, Schimeczek M, Hoffmann RW.
PMID: 29711393
Angew Chem Int Ed Engl. 1998 Apr 03;37(6):824-826. doi: 10.1002/(SICI)1521-3773(19980403)37:6<824::AID-ANIE824>3.0.CO;2-6.

An intermediate with a half-life of 30 minutes has been observed in the iodine-magnesium exchange reaction of 1,1-diiodoalkanes in THF at -78°C. This intermediate is likely the ate complex 1. Its characteristic chemistry calls for a mechanistic reconsideration of...

Cite
Schulze V, Brönstrup M, Böhm VPW, et al. α-Iodoalkyl-Iodine-Ate Complexes as Observable Intermediates in the Iodine- Magnesium Exchange Reaction. Angew Chem Int Ed Engl. 1998;37(6):824-826doi: 10.1002/(SICI)1521-3773(19980403)37:6<824::AID-ANIE824>3.0.CO;2-6.
Schulze, V., Brönstrup, M., Böhm, V. P. W., Schwerdtfeger, P., Schimeczek, M., & Hoffmann, R. W. (1998). α-Iodoalkyl-Iodine-Ate Complexes as Observable Intermediates in the Iodine- Magnesium Exchange Reaction. Angewandte Chemie (International ed. in English), 37(6), 824-826. https://doi.org/10.1002/(SICI)1521-3773(19980403)37:6<824::AID-ANIE824>3.0.CO;2-6
Schulze, Volker, et al. "α-Iodoalkyl-Iodine-Ate Complexes as Observable Intermediates in the Iodine- Magnesium Exchange Reaction." Angewandte Chemie (International ed. in English) vol. 37,6 (1998): 824-826. doi: https://doi.org/10.1002/(SICI)1521-3773(19980403)37:6<824::AID-ANIE824>3.0.CO;2-6
Schulze V, Brönstrup M, Böhm VPW, Schwerdtfeger P, Schimeczek M, Hoffmann RW. α-Iodoalkyl-Iodine-Ate Complexes as Observable Intermediates in the Iodine- Magnesium Exchange Reaction. Angew Chem Int Ed Engl. 1998 Apr 03;37(6):824-826. doi: 10.1002/(SICI)1521-3773(19980403)37:6<824::AID-ANIE824>3.0.CO;2-6. PMID: 29711393.
Copy Download .nbib Format: NLM
Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?.

Leukemia supplements

Kolb HJ, Schmetzer H, Schmid C, Bigalke I, Buhmann R, Moosmann A, Falk C, Reuther S, Schuster F, Borkhardt A.
PMID: 27175264
Leuk Suppl. 2014 Dec;3:S16-7. doi: 10.1038/leusup.2014.9. Epub 2014 Dec 17.

No abstract available.

Cite
Kolb HJ, Schmetzer H, Schmid C, et al. Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?. Leuk Suppl. 2014;3:S16-7doi: 10.1038/leusup.2014.9.
Kolb, H. J., Schmetzer, H., Schmid, C., Bigalke, I., Buhmann, R., Moosmann, A., Falk, C., Reuther, S., Schuster, F., & Borkhardt, A. (2014). Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?. Leukemia supplements, 3S16-7. https://doi.org/10.1038/leusup.2014.9
Kolb, H-J, et al. "Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?." Leukemia supplements vol. 3 (2014): S16-7. doi: https://doi.org/10.1038/leusup.2014.9
Kolb HJ, Schmetzer H, Schmid C, Bigalke I, Buhmann R, Moosmann A, Falk C, Reuther S, Schuster F, Borkhardt A. Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?. Leuk Suppl. 2014 Dec;3:S16-7. doi: 10.1038/leusup.2014.9. Epub 2014 Dec 17. PMID: 27175264; PMCID: PMC4851289.
Copy Download .nbib Format: NLM
In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS.

Journal of immunotherapy (Hagerstown, Md. : 1997)

Freudenreich M, Tischer J, Kroell T, Kremser A, Dreyßig J, Beibl C, Liepert A, Kolb HJ, Schmid C, Schmetzer H.
PMID: 34864807
J Immunother. 2021 Dec 06; doi: 10.1097/CJI.0000000000000404. Epub 2021 Dec 06.

Allogeneic stem cell transplantation (alloSCT) is the treatment of choice for many patients with acute myeloid leukemia (AML) and myelodysplastic syndrome. The presentation of leukemic or allospecific antigens by malignant blasts is regarded as a crucial trigger for an...

Cite
Freudenreich M, Tischer J, Kroell T, et al. In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS. J Immunother. 2021;doi: 10.1097/CJI.0000000000000404.
Freudenreich, M., Tischer, J., Kroell, T., Kremser, A., Dreyßig, J., Beibl, C., Liepert, A., Kolb, H. J., Schmid, C., & Schmetzer, H. (2021). In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS. Journal of immunotherapy (Hagerstown, Md. : 1997), . https://doi.org/10.1097/CJI.0000000000000404
Freudenreich, Markus, et al. "In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS." Journal of immunotherapy (Hagerstown, Md. : 1997) vol. (2021). doi: https://doi.org/10.1097/CJI.0000000000000404
Freudenreich M, Tischer J, Kroell T, Kremser A, Dreyßig J, Beibl C, Liepert A, Kolb HJ, Schmid C, Schmetzer H. In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS. J Immunother. 2021 Dec 06; doi: 10.1097/CJI.0000000000000404. Epub 2021 Dec 06. PMID: 34864807.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries